Wedica 100 Tablet 16 pcs

8,424

Quantity: 1

Wedica is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is a highly selective
dipeptidyl peptidase-4 inhibitor that is typically used as an add on treatment when the first line treatment of metformin is not achieving the
expected glycemic goals; though it has been approved for use as a first line treatment when metformin cannot be used.

Product Warranty

Payment Methods

payment-logo

About the Product

Full Description

Dosage & Administration: 100 mg of Wedica is administered to adults once weekly by mouth. This has lesser hypoglycemic events and 4 and 12-fold more potent than Alogliptin and Sitagliptin.

Side Effects: Among 901 domestic clinical trial cases up to the time of approval, 103 cases ( 11.4%) showed clinical results that included abnormalities and side effects. These mainly included hypoglycemia, nasopharyngitis, and elevated lipase. Given the appearance of serious side effects such as  ypoglycemia (0.1~5%) , administer medication in conjunction with close observation of patient status. Other DPP-4 inhibitors have been reported to present serious hypoglycemia in combination with Sulfonylurea medications as well as some cases of loss of consciousness. Moreover, decreased blood sugar from the use of this medication, once confirmed, can be remedied by giving sucrose. However, hypoglycemia resulting from a combination with glucosidase inhibitors should be treated with fructose.

 

Reviews:


No Review



Cart

0 Items

0
Cart 0 Item
close
close

Your purchase will delivered in 1 shipment

Express delivery
Empty

Your shopping bag is empty. Start shopping now.